key: cord-0819546-r8vqp2r0
authors: Liu, Jiao; Zhang, Lidi; Chen, Yizhu; Wu, Zhixiong; Dong, Xuan; Teboul, Jean-Louis; Zhang, Sheng; Ye, Xiaofei; Liu, Yongan; Wang, Tao; Du, Hangxiang; Li, Wenzhe; Chen, Dechang
title: Association of sex with clinical outcomes in COVID-19 patients: A retrospective analysis of 1190 cases
date: 2020-09-28
journal: Respir Med
DOI: 10.1016/j.rmed.2020.106159
sha: 27ac823eebe7a39b3c68741a80a73a68b4baeb8b
doc_id: 819546
cord_uid: r8vqp2r0

BACKGROUND: The outbreak of COVID-19 caused by SARS-CoV-2 has been a pandemic. The objective of our study was to explore the association between sex and clinical outcomes in patients with COVID-19. METHODS: Detailed clinical data including clinical characteristics, laboratory tests, imaging features and treatments of 1190 cases of adult patients with confirmed COVID-19 were retrospectively analyzed. Associations between sex and clinical outcomes were identified by multivariable Cox regression analysis. RESULTS: There were 635 (53.4%) male and 555 (46.6%) female patients in this study. Higher rates of acute kidney injury (5.5% vs. 2.9%, p = 0.026), acute cardiac injury (9.1% vs. 4.3%, p = 0.001), and disseminated intravascular coagulation (2.5% vs. 0.7%, P = 0.024) were observed in males. Compared with female patients, male patients with COVID-19 had a higher inhospital mortality rate (15.7% vs. 10.3%, p = 0.005). However, Cox regression analysis showed that sex did not influence inhospital mortality of COVID-19 patients. CONCLUSIONS: Male sex was associated with a worse prognosis of COVID-19, but it seems not to be an independent prognostic factor.

The outbreak of novel coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [1] , has rapidly turn into a pandemic. To 26 July 2020, it has affected more than 15,700,000 cases and claimed more than 640,000 lives (https://covid19.who.int). Although the disease is now better contained in China, the prevalence in other parts of the world remains serious.

Researches on underlying mechanism of COVID-19 outcomes become urgent worldwide.

Published studies from multiple countries on clinical characteristics of the disease have indicated that males appear with higher incidence and mortality of COVID-19 than females [2] [3] [4] [5] . One study of 44672 patients with confirmed COVID-19 in Mainland China, carried out by the Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, found the male-to-female ratio in China overall was 1.06:1, case fatality rate for males was 2.8% and for females was 1.7% [3] . In a study of 1099 patients with COVID-19 from 552 hospitals in 30 provinces in China, the male-to-female ratio was 1.39:1 [4] . Italian epidemiologic data showed the male-to-female ratio was up to 3:1 for SARS-CoV-2 infection [5] .

Given the sex-based disparity in incidence and hospitalization, as well as in mortality, the clinical characteristics of the disease need to be stratified by sex. In the present study, we analyzed 1190 adult patients with confirmed COVID-19 in Wuhan J o u r n a l P r e -p r o o f Infectious Disease Hospital, to explore the association between sex and clinical outcomes of COVID-19 in Chinese population.

This study was approved by the Medicine Institutional Review Board of Wuhan All patients enrolled in this study were diagnosed according to World Health Organization interim guidance [6] . Nasal and pharyngeal-swab specimens from patients with history of epidemiology and characteristics of virus pneumonia in chest computed tomographic (CT) or X-ray were obtained. Patients with positive results from high-throughput sequencing or real-time reverse-transcriptasepolymerase-chain-reaction (RT-PCR) assay of nasal and pharyngeal swab specimens were confirmed with COVID-19.

Epidemiological, demographic, clinical, laboratory and radiological data, treatments and outcomes data were extracted from medical records. The data were reviewed by a trained team of physicians. Information collected included age, sex, comorbidities, J o u r n a l P r e -p r o o f exposure history, laboratory findings, chest CT and x-ray scans, respiratory support during hospitalization, therapeutic strategy and outcomes.

Acute respiratory distress syndrome (ARDS) was defined according to the Berlin definition [7] . Acute kidney injury (AKI) was identified according to the Kidney Disease: Improving Global Outcomes definition [8] . Acute cardiac injury (ACI) was defined if the serum levels of cardiac biomarkers were above the 99th percentile upper reference limit or new abnormalities were shown in electrocardiography and echocardiography [9] . Acute hepatic injury (AHI) was identified as total bilirubin increase by 51.3 μmol/L and alanine aminotransferase increase to five times the upper reference limit. Platelet counts, prothrombin time test, and the levels of fibrin/fibrinogen degradation products (FDPs) were components in the major sets of diagnostic criteria of disseminated intravascular coagulation (DIC) [10] . The sequential organ failure assessment (SOFA) and acute physiology and chronic health evaluation II (APACHE II) scores were determined on admission.

Continuous variables were described as mean (95% confidence interval), or as median 

There were numerous differences in laboratory findings between male and female patients ( Table 2) We also analyzed sex differences in chest radiological findings and therapies during hospitalization. The radiological findings were similar in males and females. However, male patients were more likely to receive glucocorticoids during hospitalization than female patients (30.7% vs. 20.6%, p<0.001).

Calculations of clinical outcomes were stratified by sex and were summarized in clinical outcomes, we compared organ failure and inhospital mortality between males and females in different age groups. As shown in Figure 2 and 3, the rates of organ failure occurrence and mortality of males and females both increased with age. In patients older than 65 years, male patients had significantly higher incidences of organ failure and inhospital mortality over female patients.

Our multivariable Cox regression model revealed no relation between sex and inhospital mortality ( 

With the intensification of the adverse impact of COVID-19 pandemic to the world, lots of studies on biological and clinical characteristics of the disease have been published. Official Chinese statistics showed that the male-to-female ratio was 1.06:1

in China and the fatality rate for males was 2.8% versus 1.7% for females [3] . Given J o u r n a l P r e -p r o o f the sex differences in case fatality rate, the clinical characteristics of the disease need to be stratified by sex.

In our study, male patients showed significantly increased incidence of acute kidney injury, acute cardiac injury and DIC, as well as higher inhospital mortality.

Angiotensin-converting enzyme 2 (ACE2), the main binding site for the entry of SARS-CoV-2 into host cells, is predominantly expressed in heart, kidney, and testis [11] [12] [13] . This may explain the vulnerability of cardiovascular system and kidney to SARS-CoV-2 infection. However, after stratification by age group, significant gender differences in organ failure and mortality were observed only in patients older than 65 years. Interestingly, males of all ages showed higher levels of organ and coagulation function parameters than that in age-matched female patients. Biological sex, age, as well as gender-associated lifestyle behaviors and comorbidities might contribute to the disparity between men and women in COVID-19 outcomes.

Unhealthy lifestyle behaviors like smoking and drinking are prevalent in males.

Alcohol and pathogenic constituents of tobacco smoke including nitric oxide, carbon monoxide and phenolic free radicals has proved proinflammatory [14] [15] [16] . What's more, active smoking has been shown to raise ACE2 receptor expression in the lungs, which increases SARS-CoV-2 attachment and entry into alveolar epithelial cells [17, 18] .

Comorbidities that are associated with fatal COVID-19 cases in the study, include diabetes, hypertension, heart disease, stock and chronic obstructive pulmonary disease J o u r n a l P r e -p r o o f (supplementary Table 1 ). Among these comorbidities, hypertension occurs more frequently in male patients. Obesity, hypertension and diabetes in the context of metabolic syndrome is considered to provide a permissive inflammatory environment that intensifies a rapid development of cytokine storm which is associated with COVID-19 severity [19, 20] . In spite of the marked sex differences in organ function and mortality in the univariate analysis, we found no relation between sex and hospital deaths in multivariable analysis, which showed that SOFA score, lymphocytopenia, thrombocytopenia and elevated D-dimer were all independent prognostic factors. We conclude that the sex underlying mechanisms are not strong enough to significantly alter such a complex and multifactorial endpoint inhospital mortality. Clinical outcomes are not only related to patients' conditions and disease severity, but also closely related to treatment including respiratory support, glucocorticoid and antiviral therapy. In the study, more males were treated with glucocorticoid due to severe disease. COX

proportional regression analysis showed that glucocorticoid therapy reduced the inhospital mortality. Although glucocorticoid therapy of COVID-19 remains controversial and might impact the inhospital mortality, but given comparing men vs.

women, the main aim of this study, the bias may be minimized.

This study had some limitations. Firstly, although our research was based on a large population, this was a retrospective single-center study with all patients enrolled from 

In summary, male sex was associated with a worse prognosis of COVID-19, but it seems not to be an independent prognostic factor.

We thank all the staffs in Wuhan Infectious Disease Hospital to take care of COVID-19 patients, and all the patients and their families included in the current study.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

A novel coronavirus from patients with pneumonia in China

Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China. China CDC Weekly

Clinical Characteristics of Coronavirus Disease 2019 in China

Mortality rate and gender differences in COVID-19 patients dying in Italy: A comparison with other countries

Clinical management of severe acute respiratory infection when novel coronavirus ( 2019-nCoV) infection is suspected: interim guidance

Acute respiratory distress syndrome: the Berlin definition

Reading between the (guide)lines--the KDIGO practice guideline on acute kidney injury in the individual patient

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Disseminated intravascular coagulation: an update on pathogenesis and diagnosis

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients

Endothelial cell infection and endotheliitis in COVID-19

Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study

Effects of nitrogen monoxide and carbon monoxide on molecular and cellular iron metabolism: mirror-image effector molecules that target iron

Nuclear factor-kappaB activation is higher in peripheral blood mononuclear cells of male smokers

Sex difference and smoking predisposition in patients with COVID-19

COVID-19 and smoking: A systematic review of the evidence

Inflammatory mechanisms linking obesity and metabolic disease

Sex and Gender Differences in the Outcomes of Vaccination over the Life Course

The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases

Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases

Stronger inflammatory/cytotoxic T-cell response in women identified by microarray analysis

Abbreviation: prothrombin time, PT

AST; blood urea nitrogen, BUN; serum creatinine, SCr; creatine kinase isoenzyme, CKMB; hyper-sensitive C-reactive protein, hsCRP; procalcitonin, PCT

interleukin, IL; mechanical ventilation, MV; extracorporeal membrane oxygenation

Duration of in-hospital stay, Median (IQR)-days 11

In-hospital mortality-n (%)

Abbreviation: acute respiratory distress syndrome, ARDS; acute kidney injury, AKI; acute hepatic injury, AHI; acute cardiac injury, ACI; disseminated intravascular coagulation